ライフサイエンスコーパス: Babesia microti

1 ic cycle, including Borrelia burgdorferi and Babesia microti.

2 burgdorferi, Anaplasma phagocytophilum, and Babesia microti.

3 sfection method has not been established for Babesia microti.

4 and molecular tests for the causative agent, Babesia microti.

5 gnosed by peripheral red blood cell smear as Babesia microti.

6 tic Ehrlichia sp., Borrelia burgdorferi, and Babesia microti.

7 ere coinfected with Borrelia burgdorferi and Babesia microti.

8 re highly efficacious against B. duncani and Babesia microti.

9 A point mutation in the Babesia microti 23S rRNA gene predicted resistance to az

10 nfections with Borrelia burgdorferi (33.6%), Babesia microti (8.4%), Anaplasma phagocytophila (1.9%),

11 this parasite to be most closely related to Babesia microti (97.9% sequence similarity); sera from i

12 the United States is caused predominantly by Babesia microti, a tick-transmitted blood parasite.

13 Babesia microti, a tick-transmitted, intraerythrocytic p

14 Babesia microti, a tickborne intraerythrocytic parasite

15 Babesia microti, a zoonotic intraerythrocytic parasite,

16 ding West Nile virus, Zika virus (ZIKV), and Babesia microti Although there is continual need to moni

17 Babesia microti, an emerging human pathogen, is primaril

18 nel detected three coinfections, with two of Babesia microti and A. phagocytophilum and one of B. mic

19 Borellia burgdorferi, Babesia microti and Anaplasma phagocytophilum rely almos

20 pecies in vitro, is highly effective against Babesia microti and Babesia duncani in mice and protects

21 east and upper Midwest of the United States, Babesia microti and Borrelia burgdorferi use Ixodes scap

22 ly caused by the intraerythrocytic parasite, Babesia microti and transmitted by the same tick as Lyme

23 s including Borrelia burgdorferi sensu lato, Babesia microti, and Anaplasma phagocytophilum.

24 agent of human monocytic ehrlichiosis (HME), Babesia microti, and Borrelia burgdorferi.

25 burgdorferi, babesiosis, which is caused by Babesia microti, and human granulocytic ehrlichiosis (HG

26 in indirect fluorescent-antibody tests with Babesia microti antigen, however, suggesting that they r

27 nsient as well as stable transfection of the Babesia microti (B. microti) in the in vivo conditions.

28 ansplant recipient who survived infection by Babesia microti contracted through blood transfusion.

29 s and fatalities of babesiosis are caused by Babesia microti Current treatment for human babesiosis c

30 Serologic evidence of exposure to Babesia microti did not significantly impact the clinica

31 arasites could be seen on microscopy, and no Babesia microti DNA was detected in the blood of any sub

32 The Babesia microti genome showed a classical Rabl organizat

33 sitive, and accurate method for detection of Babesia microti in patient specimens.

34 um vivax malaria, has shown activity against Babesia microti in several animal models of acute infect

35 testing were used to confirm the presence of Babesia microti in the donor's blood and to establish th

36 aneous infection of Borrelia burgdorferi and Babesia microti in the northeastern and northern midwest

37 of coinfection with Borrelia burgdorferi and Babesia microti in tick vectors, reservoir hosts, and pa

38 ty of infection with a common microparasite, Babesia microti, in females - with females carrying the

39 valuated the efficacy of TQ for treatment of Babesia microti infection in mice with severe combined i

40 y who were suspected of local acquisition of Babesia microti infection.

41 t surveyed B. miyamotoi, B. burgdorferi, and Babesia microti infections.

42 - and transfusion-transmitted human pathogen Babesia microti infects host erythrocytes to cause the p

43 Babesia microti is a tick-borne red blood cell parasite

44 Human babesiosis caused by Babesia microti is an emerging tick-borne zoonosis of in

45 Babesia microti is an intraerythrocytic parasite and the

46 long-term carriers of the zoonotic parasite Babesia microti is evidenced by numerous reported cases

47 Although infection by the protozoan Babesia microti is rarely symptomatic in immunocompetent

48 The apicomplexan pathogen Babesia microti is responsible for most cases of human b

49 Babesia microti is the cause of a potentially fatal emer

50 babesiosis, which is caused by the piroplasm Babesia microti, is made by microscopic identification o

51 The major species, Babesia microti, is readily transmissible via blood tran

52 besiosis, a zoonosis caused by the protozoan Babesia microti, is usually not treated when the symptom

53 A new strain of Babesia microti (KR-1) was isolated from a Connecticut r

54 Crystal structures of Babesia microti lactate dehydrogenase BmLDH reveal a cri

55 Tickborne transmission of Babesia microti mainly occurs in 7 states in the Northea

56 Here, we show that a mutation in the Babesia microti mitochondrial cytochrome b (Cytb) that c

57 rently infected with Borrelia burgdorferi or Babesia microti (or both).

58 gainst a panel of 24 organisms consisting of Babesia microti, other Babesia species, Plasmodium speci

59 atment of babesiosis, including clearance of Babesia microti parasitemia.

60 abesia divergens-like/MO-1 organisms and not Babesia microti, the common United States species.

61 ime PCR assay targeting the 18S rRNA gene of Babesia microti, the dominant babesiosis pathogen in the

62 ted States have been tickborne and caused by Babesia microti, the etiologic agent of all previously d

63 The intraerythrocytic apicomplexan Babesia microti, the primary causative agent of human ba

64 For Borrelia burgdorferi and Babesia microti, the sensitivity of TBDCapSeq was compar

65 acted from whole-blood specimens and detects Babesia microti with a limit of detection of approximate